Since ADIPO and LEP activate antagonistic intracellular signaling pathways [15], it appears that the ratio of ADIPO:LEP may be a more reliable predictor of cancer incidence and outcome in breast cancer patients [2,16]. This evidence concerns the gene LEP and breast carcinoma.